Yifan Pharmaceutical Co., Ltd. (SHE:002019)
15.58
+0.59 (3.94%)
Sep 5, 2025, 3:04 PM CST
Yifan Pharmaceutical Market Cap
Yifan Pharmaceutical has a market cap or net worth of 18.95 billion as of September 5, 2025. Its market cap has increased by 27.29% in one year.
Market Cap
18.95B
Enterprise Value
20.35B
Revenue
5.16B
Ranking
n/a
PE Ratio
43.22
Stock Price
15.58
Market Cap Chart
Since August 23, 2004, Yifan Pharmaceutical's market cap has increased from 929.25M to 18.95B, an increase of 1,939.43%. That is a compound annual growth rate of 15.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 5, 2025 | 18.95B | 45.34% |
Dec 31, 2024 | 13.04B | -27.61% |
Dec 29, 2023 | 18.01B | 19.94% |
Dec 30, 2022 | 15.02B | -30.93% |
Dec 31, 2021 | 21.74B | -6.96% |
Dec 31, 2020 | 23.37B | 36.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 482.35B |
WuXi AppTec | 313.22B |
Shenzhen Mindray Bio-Medical Electronics | 287.79B |
Sichuan Biokin Pharmaceutical | 155.60B |
Zhangzhou Pientzehuang Pharmaceutical., | 123.00B |
Aier Eye Hospital Group | 120.10B |
Shanghai United Imaging Healthcare | 116.97B |
Yunnan Baiyao Group Co.,Ltd | 105.81B |